Dear Colleagues:

Following an extensive national search, it is with great pleasure that I announce the appointment of Eldrin Lewis, MD, MPH as Professor of Medicine and Division Chief, Cardiovascular Medicine, Department of Medicine, effective March 1, 2020. Eldrin succeeds Drs. Tom Quertermous and Alan Yeung who have successfully led the division as a collaborative partnership over the last 20+ years.

Eldrin, a Mississippi native, received his BS at Penn State and his MD from the University of Pennsylvania.  He has an MPH from the Harvard School of Public Health. He did his internal medicine residency and fellowships in cardiovascular medicine as well as advanced heart failure and transplant cardiology at the Brigham and Women’s Hospital (BWH) in Boston.  He joined the faculty of Harvard Medical School and the Brigham and Women’s Hospital in 2002 and was promoted to Associate Professor of Medicine in 2015.

He has served in a number of leadership roles at the BWH and nationally through the American Heart Association (AHA), where he is the current chair of the Council on Clinical Cardiology and the Association of Black Cardiologists, where he serves as the Research Chair.

Eldrin is an outstanding clinician-scientist who specializes in the care of the patient with advanced heart failure.  He is an accomplished clinical researcher with deep expertise in the conduct of clinical trials examining diagnostic and therapeutic approaches to heart failure. More recently, he has done innovative work in creating systems of incorporating quality of life measures for cardiovascular patients into the electronic health record.  His research has been supported by NIH, private industry and foundations and has been published in the top general medical and cardiovascular journals. He has a long track record of mentorship and is a regular author of professional society clinical practice guidelines and scientific statements from both the AHA and the FDA.

Please join me in welcoming Eldrin to the Stanford Medicine community and to this new leadership role.  We expect that he will build upon the clinical, training and scientific legacy established by TQ and Alan while also taking the Division of Cardiovascular Medicine to even greater heights! Thanks also to the search committee, chaired by Drs. Joe Woo, Chair of Cardiothoracic Surgery, and Joe Wu, Director of the Cardiovascular Institute, for their hard work and outstanding leadership.

Robert A. Harrington, MD

Arthur L. Bloomfield Professor

Chair, Department of Medicine